By better understanding daily activity levels and heart rate patterns of those who suffer from Chronic Fatigue Syndrome (CFS), scientists hope to discover more about this complex illness condition.
Dr. John J. Warner, Vice President and Chief Executive Officer of UT Southwestern Medical Center University Hospitals, will become President-Elect of the American Heart Association on July 1 for 2016-2017, then serve as President of the AHA for the 2017-2018 year.
Raymond R. Townsend, MD, director of the Hypertension Program and a professor of Medicine in Perelman School of Medicine at the University of Pennsylvania, has been named the 2016 Physician of the Year Award of the American Heart Association (AHA).
A UCLA-led study estimates that almost 28,500 deaths could be prevented each year in the U.S. through use of a new FDA-approved class of cardiovascular medication that helps reduce mortality in patients diagnosed with heart failure and reduced ejection fraction, the percentage of blood pumped from the heart with each contraction.
Researchers at the George Washington University received $1.6 million from the National Heart, Lung, and Blood Institute to find ways to restore parasympathetic activity to the heart through oxytocin neuron activation. This heart-brain connection could improve cardiac function during heart failure.
In a study appearing in the June 21 issue of JAMA, Peter Ganz, M.D., of the University of California-San Francisco, and colleagues conducted a study to develop and validate a score to predict risk of cardiovascular outcomes among patients with coronary heart disease using analysis of circulating proteins.
A University of North Carolina School of Medicine scientist has been awarded an inaugural global award from Science and Science Translational Medicine and Boyalife for her research in healing damaged heart muscle.
Low dose aspirin is recommended by clinicians as a preventive measure for patients who have already had a heart attack or stroke, but the risk of taking low-dose aspirin to prevent or delay a first heart attack or stroke is less clear, as the benefit for reducing the risk of cardiovascular disease (CVD) must be balanced with the increased risk of gastrointestinal or other bleeding. To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, "Aspirin-Guide" that calculates both the CVD risk score and the bleeding risk score for the individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin (75 to 81 mg daily).
Loyola University Chicago is hosting a June 22 workshop on three giant proteins that play critical roles in heart disease. The conference is titled, "Titin and its binding partners, myosin binding protein-C and obscurin in health and disease."
The heart is the only muscle that contracts and relaxes continuously over a lifetime to pump oxygen-rich blood to the body’s organs. Researchers at UT Southwestern Medical Center now have identified a previously unrecognized enzyme that could optimize contraction and lead to new strategies to treat heart failure.
Researchers at University of California San Diego School of Medicine and University of California, San Francisco School of Medicine report that more than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin alone, despite previous data showing this therapy to be inferior to blood thinners.
VentureMed Group, Ltd., a medical device company based in northwest Ohio, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the commercial distribution of a new surgical device for treating peripheral artery disease (PAD). It’s called the FLEX Scoring Catheter® and was developed by ProMedica Vascular Surgeon John Pigott, MD, as an alternative to balloon-based scoring with a one-size-fits-all platform technology.
PinnacleHealth enrolled the first patient nationally in a new clinical trial investigating a larger size of the Medtronic CoreValve® Evolut® R System—the Evolut R 34mm System.
Measuring antibody levels in the blood could be used to detect a person’s heart attack risk after researchers, part-funded by the British Heart Foundation (BHF), discovered that higher levels of these antibodies are linked to a lower heart attack risk.
Jersey Shore University Medical Center and Ocean Medical Center, both part of Meridian CardioVascular Network, have received the Get With The Guidelines®-Heart Failure Gold Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology Foundation’s secondary prevention guidelines for patients with heart failure.
Dr. Douglas Lee, an internationally-known Peter Munk Cardiac Centre cardiologist and scientist, has been selected as first-ever chair for the Ted Rogers Centre for Heart Research, a Toronto collaboration aiming to transform the care of children and adults with heart failure.
Riverview Medical Center, part of Meridian CardioVascular Network, has received the Get With The Guidelines®-Heart Failure Silver Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology Foundation’s secondary prevention guidelines for patients with heart failure.
In this month’s release, find new embargoed research about return on investment in public health; cardiovascular risks for U.S. women; and effects of increased minimum wage on infant mortality.
Researchers at Johns Hopkins report that a type of lab-grown human nerve cells can partner with heart muscle cells to stimulate contractions. Because the heart-thumping nerve cells were derived from induced pluripotent stem (iPS) cells, the researchers believe the cells — known as sympathetic nerve cells — will allow them to grow nerve cells that replicate particular patients’ diseases of the nervous system.